Huntington Predicts CareTrust REIT FY2026 Earnings

CareTrust REIT, Inc. (NYSE:CTRE) – Huntington issued their FY2026 EPS estimates for CareTrust REIT in a report released on Thursday, November 5th. Huntington analyst R. Stevenson forecasts that the company will earn $2.05 per share for the year. Huntington currently has an “Outperform” rating and a $44.00 target price on the stock. The consensus estimate for CareTrust REIT’s current full-year earnings is $2.07 per share. Huntington also issued estimates for CareTrust REIT’s Q4 2026 earnings at $0.55 EPS, Q1 2027 earnings at $0.56 EPS, Q2 2027 earnings at $0.57 EPS, Q3 2027 earnings at $0.58 EPS, Q4 2027 earnings at $0.59 EPS, FY2027 earnings at $2.31 EPS, Q1 2028 earnings at $0.59 EPS, Q2 2028 earnings at $0.60 EPS, Q3 2028 earnings at $0.61 EPS and FY2028 earnings at $2.43 EPS.

Other equities research analysts have also recently issued reports about the company. KeyCorp reissued an “overweight” rating on shares of CareTrust REIT in a report on Tuesday, October 6th. Citigroup reaffirmed a “market outperform” rating on shares of CareTrust REIT in a research note on Tuesday, October 13th. Raymond James Financial cut their target price on CareTrust REIT from $45.00 to $42.00 and set an “outperform” rating for the company in a research report on Monday, October 5th. JPMorgan Chase & Co. began coverage on CareTrust REIT in a research note on Friday, October 16th. They set a “neutral” rating and a $41.00 target price on the stock. Finally, Royal Bank Of Canada reissued a “sector perform” rating and issued a $43.00 price target on shares of CareTrust REIT in a report on Monday, October 5th. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, CareTrust REIT currently has a consensus rating of “Moderate Buy” and a consensus price target of $43.64.

CareTrust REIT Trading Up 1.6%

Shares of CTRE stock opened at $38.81 on Tuesday. CareTrust REIT has a 52-week low of $34.74 and a 52-week high of $43.62. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.57 and a current ratio of 0.57. The firm has a market capitalization of $9.17 billion, a PE ratio of 19.87, a PEG ratio of 1.35 and a beta of 0.77. The stock has a fifty day simple moving average of $37.27 and a two-hundred day simple moving average of $38.99.

CareTrust REIT (NYSE:CTRE) last released its earnings results on Thursday, November 5th. The company reported $0.54 earnings per share for the quarter, beating analysts’ consensus estimates of $0.52 by $0.02. The company had revenue of $176.36 million for the quarter. CareTrust REIT had a net margin of 62.19% and a return on equity of 8.52%.

CareTrust REIT Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, October 15th. Shareholders of record on Wednesday, September 30th were paid a $0.39 dividend. The ex-dividend date was Wednesday, September 30th. This represents a $1.56 annualized dividend and a yield of 4.0%. CareTrust REIT’s payout ratio is presently 98.11%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in CTRE. BlackRock Inc. purchased a new position in shares of CareTrust REIT during the second quarter valued at about $1,643,290,000. Deutsche Bank AG bought a new stake in shares of CareTrust REIT in the second quarter worth about $143,963,000. Dimensional Fund Advisors LP lifted its position in shares of CareTrust REIT by 1.9% in the first quarter. Dimensional Fund Advisors LP now owns 3,333,252 shares of the company’s stock worth $122,164,000 after buying an additional 61,417 shares in the last quarter. Bank of New York Mellon Corp lifted its position in shares of CareTrust REIT by 5.2% in the first quarter. Bank of New York Mellon Corp now owns 2,558,104 shares of the company’s stock worth $93,755,000 after buying an additional 127,138 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of CareTrust REIT by 35,170.9% in the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,411,896 shares of the company’s stock worth $56,970,000 after buying an additional 1,407,893 shares in the last quarter. Institutional investors own 87.77% of the company’s stock.

Key Stories Impacting CareTrust REIT

Here are the key news stories impacting CareTrust REIT this week:

• Positive Sentiment: Huntington projects EPS of $2.05 for FY2026, rising to $2.31 in FY2027 and $2.43 in FY2028, and maintains a $44 target. Against the provided $38.81 opening price, that target implies roughly 13% potential appreciation. CareTrust REIT analyst estimates
• Positive Sentiment: A separate report headline puts the brokerage consensus target at $43.64, also above the provided opening price. CareTrust REIT consensus target price
• Neutral Sentiment: Huntington’s FY2026 EPS estimate of $2.05 is slightly below the cited analyst consensus of $2.07. The available reports do not describe a new business development or a change in rating, so the estimates may offer limited fresh direction for the shares.

CareTrust REIT Company Profile

CareTrust REIT, Inc is a real estate investment trust that owns and invests in healthcare-related properties, with a focus on skilled nursing facilities and senior housing. Its portfolio also includes assisted living and other properties that serve older adults and people requiring healthcare services.

The company primarily works with healthcare operators through long-term property leases and other real estate investments. CareTrust’s properties are located across the United States, and the company has expanded its investments into the United Kingdom.

CareTrust became an independent publicly traded company in 2014 after separating from The Ensign Group, a healthcare services provider.